Home
About
Services
Partners
Client Portfolio
News
Contact
Disney parks lift earnings, ‘Avengers: Endgame’ streaming date announced
May 9, 2019
BlackRock pulls out of rescue bid for Italian bank Carige
May 9, 2019
0
Takeda sells dry eye drug to Novartis to help cut debt
Published by
Muller&Green
at
May 9, 2019
Categories
RSS
Tags
Takeda Pharmaceutical Co Ltd agreed to sell its dry eye drug to Swiss drugmaker Novartis AG for $3.4 billion and potential milestone payments of up to $1.9 billion, in the first divestment since its takeover of Britain’s Shire.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more